Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in omics research, from discovery and multi-omics approaches through to diagnostics development

Spatial Revolution: Harnessing Spatial Technologies In The Clinic For A Healthier Tomorrow

Envisioning a future where spatial technologies pave the way for more accurate diagnoses, targeted treatments, and ultimately, improved patient outcomes. Download our eBook today!
Read Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Genome Editing

Machine Learning Algorithm Measures Prime Editing Efficiency

Wellcome Sanger Institute propose a new machine learning algorithm for predicting genome editing efficiency for the CRISPR-Cas9-based approach of prime editing.
Read More
Genome Editing

Recent Advances and the Future Landscape of Genome Editing For Disease Models And How This Has Helped Us Gain Insight Into Disease Biology 

In Conversation With Laralynne Pryzbyla, Adjunct Assistant Professor at UCSF & UC Scientific Director, Laboratory for Genomics Research
Read More
Spatial Biology

Regulation & Policy: Interview with Arvind Rao, Associate Professor of Biostatistics at the University of Michigan

Arvind Rao, Associate Professor of Biostatistics at the University of Michigan, discusses the regulatory challenges and opportunities of biomedical informatics.
Read More
Genome Editing

Regulation & Policy: Interview with John Parrington, Associate Professor of Cellular and Molecular Pharmacology, University of Oxford

John Parrington, Associate Professor of Cellular and Molecular Pharmacology & Fellow of Worcester College, University of Oxford, discusses the regulatory challenges and opportunities of genome editing.
Read More
Single Cell Analysis

Navigating Post-Translational Modifications in Single-Cell Analysis

What are the current opportunities and challenges facing single-cell analysis today? We ask key opinion leaders from Janssen Pharmaceuticals, SciLifeLab, and the Karolinska Institutet.
Read More
Genome Editing

Policy Issues for Responsible Genomics Research

Responsible genomics research is vital to ensuring the advancement of health for society. But what are the ethical, social, and legal considerations that go into genomics-based decision making?
Read More
NGS & Clinical Diagnostics

Long-Read Sequencing Named 'Method of the Year 2022'

Powering a more complete reading of genomic information, Nature hails long-read sequencing as the omics-based method of the year.
Read More
Spatial Biology

The Future of Spatial Technology, Analysis, and Imaging

This Insight Article looks at the short and long-term predictions for spatial technological regulation, standardisation, and collaboration for the omics field.
Read More
NGS & Clinical Diagnostics

FDA Clears Genomic Profiling Test for Solid Tumours 

Regulatory approval for comprehensive genomic profiling test signifies “significant advancement in personalised cancer care.”
Read More
Genome Editing

FDA and NIH Sign Interagency Collaboration Agreement to Advance Proteogenomics Research

A memorandum of understanding has been reached between the U.S. Food and Drug Administration (FDA) and the National Cancer Institute (NCI) to provide a framework for solving complex problems in molecular characterisation and classification of tumours.
Read More
Genome Editing

Novel Genome Editing Techniques: What Will Come Next after CRISPR-Cas9?

The gene editing field has exploded in the last ten years, with methods such as CRISPR-Cas9 becoming well-established in the pre-clinical sphere. However, complications in clinical applications have led some researchers to explore alternatives.
Read More
Spatial Biology

Rapid Development of Spatial Signatures as Predictive Biomarkers for Immunotherapy Response

On-Demand Webinar featuring Dr Alessio Colombo, Application Scientist at Akoya
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things omics